NoveraMed is PhD-led scientific medical communications for life sciences and biopharma. When our writers review your data package, they read it as scientists, not as editors who have to ask what your MOA does.
Limited partnerships available. We work with a select number of programs to ensure the depth of engagement our clients expect.
Cutting-edge biology is extraordinarily difficult to communicate. Getting the story right for investors, HCPs, and regulators requires writers who actually understand the science they are describing.
General medical writers simplify complex biology until it loses accuracy. Specialist audiences, including KOLs, medical affairs, and investors, need precision, not approximation.
Congress abstracts, manuscript submissions, and data package timing are ruthless. Without a dedicated communications partner, critical publication windows close while your science sits in a queue.
A different agency for publications, another for HCP content, another for patient materials. None of them understanding your biology deeply enough to keep the narrative consistent across channels.
NoveraMed was built by the founders of Novera Group around a single conviction: life sciences programs deserve communications partners who genuinely understand their biology. Ranee, our Chief Scientific Officer, holds a PhD from Albert Einstein College of Medicine in immunology and oncology. She leads every scientific engagement.
Our team reads your data the way a scientist does. That foundation is what makes the difference between communications that are merely accurate and communications that are genuinely compelling.
Every engagement begins with our Audience-Platform-Content framework, ensuring the right message reaches the right audience at every stage of your program's development.
From launch narrative to congress abstracts to HCP education, one dedicated team deeply fluent in your program, from Series A through approval.
Treg
Biology
Deep Bench Expertise
Einstein
PhD
Scientific Leadership
Life
Sciences
Primary Focus
Series A
Through Approval
Client Stage

Leveraging Large Language Models trained on biomedical literature.
The scientific narrative foundation every life sciences program needs. We architect your story from the ground up, for investors, KOLs, and medical affairs, before your first major data read-out.
Do not let publication windows close on you. Our retainer model keeps a dedicated scientific writer embedded in your program, managing manuscripts, abstracts, poster submissions, and congress prep on your timeline.

Content created by subject matter experts who understand the science.
Built for life sciences and biopharma programs navigating Series A through commercial approval
Your scientific narrative foundation, built before the data reads out. MOA scripts, pipeline summaries, and KOL decks that investors and physicians can trust.
A dedicated scientific writer embedded in your program, managing the full publication and congress pipeline so no deadline is ever missed.
HCP platform content, MSL field force materials, and patient-facing disease awareness, all scientifically accurate and compliantly positioned.
We are not a generalist medical communications agency. We are a specialist practice built around complex biology, founded by a PhD scientist who spent years at the bench before shifting to scientific storytelling.
Ranee, our Chief Scientific Officer, holds a PhD from Albert Einstein College of Medicine, with immunology and oncology research across two of the institution's leading labs. When she reads your data, she understands it.
We built this practice around complex biology. Our writers are not generalists handed your science to summarize. They are scientists who have studied the mechanisms your program is built on.
Every engagement starts with our Audience-Platform-Content framework, ensuring your scientific story stays consistent and accurate across every channel and every stakeholder group.
AACR, ASCO, ASH, ESMO, SITC. We know the deadlines, the formats, and what reviewers expect. A retainer with NoveraMed means you never scramble before a major conference again.
We scale with your program. From the initial BioContent narrative through Phase 3 publications and HCP education, one partner who knows your biology from day one.
Built alongside Novera Group, every client gets a secure platform for project tracking, document management, and real-time program visibility.
Every client gets access to our powerful platform—complete project visibility, AI-curated intelligence, and collaboration tools.
AI-curated news, FDA alerts, and insights tailored to your therapeutic areas.
Real-time visibility into all projects, milestones, tasks, and deliverables.
Medical writer, document summarizer, and research assistant at your fingertips.
Secure document management with version control and team collaboration.
Tell us about your program. We will tell you whether NoveraMed is the right partner, and what that would look like.
Part of Novera Group
NoveraMed is a sister practice of Novera Group, a digital product studio for life sciences.